Keywords: ucb, pharma, keppra, effective, controlling, seizures, elderly
UCB Pharma's Keppra effective in controlling seizures in the elderly
Article | 22 December 2003
New findings from three US studies, presented at the American EpilepsySociety's annual meeting in Boston, demonstrated that UCB Pharma's Keppra ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
